EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 39 / No 5 (Mai 2023) Med Sci (Paris), 39 5 (2023) 437-444 References
Open Access
Issue
Med Sci (Paris)
Volume 39, Number 5, Mai 2023
Page(s) 437 - 444
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2023065
Published online 23 May 2023
  1. Thierry S, Fautrel B, Lemelle Iet al. Prevalence and incidence of juvenile idiopathic arthritis: a systematic review. Joint Bone Spine 2014 ; 81 : 112–117. [CrossRef] [PubMed] [Google Scholar]
  2. Petty RE, Southwood TR, Manners Pet al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004 ; 31 : 390–392. [PubMed] [Google Scholar]
  3. Zaripova LN, Midgley A, Christmas SE, et al. Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches. Pediatr Rheumatol Online J 2021; 19 : 135. [CrossRef] [PubMed] [Google Scholar]
  4. Prakken B, Albani S, Martini AJuvenile idiopathic arthritis. Lancet 2011 ; 377 : 2138–2149. [CrossRef] [PubMed] [Google Scholar]
  5. Rigante D, Bosco A, Esposito SThe Etiology of Juvenile Idiopathic Arthritis. Clin Rev Allergy Immunol 2015 ; 49 : 253–261. [CrossRef] [PubMed] [Google Scholar]
  6. Horton DB, Scott FI, Haynes Ket al. Antibiotic Exposure and Juvenile Idiopathic Arthritis: A Case-Control Study. Pediatrics 2015 ; 136 : e333–e343. [CrossRef] [PubMed] [Google Scholar]
  7. De Filippo C, Di Paola M, Giani T, et al. Gut microbiota in children and altered profiles in juvenile idiopathic arthritis. J Autoimmun 2019 ; 98 : 1–12. [CrossRef] [PubMed] [Google Scholar]
  8. Matsuoka K, Kanai TThe gut microbiota and inflammatory bowel disease. Semin Immunopathol 2015 ; 37 : 47–55. [CrossRef] [PubMed] [Google Scholar]
  9. Abdollahi-Roodsaz S, Joosten LAB, Koenders MI, et al. Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J Clin Invest 2008 ; 118 : 205–216. [CrossRef] [PubMed] [Google Scholar]
  10. Arvonen M, Virta LJ, Pokka T, et al. Repeated exposure to antibiotics in infancy: a predisposing factor for juvenile idiopathic arthritis or a sign of this group’s greater susceptibility to infections?. J Rheumatol 2015 ; 42 : 521–526. [CrossRef] [PubMed] [Google Scholar]
  11. Carlens C, Jacobsson L, Brandt L, et al. Perinatal characteristics, early life infections and later risk of rheumatoid arthritis and juvenile idiopathic arthritis. Ann Rheum Dis 2009 ; 68 : 1159–1164. [CrossRef] [PubMed] [Google Scholar]
  12. Kristensen K, Henriksen L. Cesarean section and disease associated with immune function. J Allergy Clin Immunol 2016 ; 137 : 587–590. [CrossRef] [PubMed] [Google Scholar]
  13. Shao Y, Forster SC, Tsaliki E, et al. Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth. Nature 2019 ; 574 : 117–121. [CrossRef] [PubMed] [Google Scholar]
  14. Rutayisire E, Huang K, Liu Y, et al. The mode of delivery affects the diversity and colonization pattern of the gut microbiota during the first year of infants’ life: a systematic review. BMC Gastroenterol 2016 ; 16 : 86. [CrossRef] [PubMed] [Google Scholar]
  15. Berntson L.. Anti-inflammatory effect by exclusive enteral nutrition (EEN) in a patient with juvenile idiopathic arthritis (JIA): brief report. Clin Rheumatol 2014 ; 33 : 1173–1175. [CrossRef] [PubMed] [Google Scholar]
  16. Di Paola M, Cavalieri D, Albanese D, et al. Alteration of Fecal Microbiota Profiles in Juvenile Idiopathic Arthritis. Associations with HLA-B27 Allele and Disease Status. Front Microbiol 2016; 7 : 1703. [CrossRef] [PubMed] [Google Scholar]
  17. van Dijkhuizen EHP, Del Chierico F, Malattia C, et al. Microbiome Analytics of the Gut Microbiota in Patients With Juvenile Idiopathic Arthritis: A Longitudinal Observational Cohort Study. Arthritis Rheumatol Hoboken NJ 2019 ; 71 : 1000–1010. [CrossRef] [PubMed] [Google Scholar]
  18. Qian X, Liu Y-X, Ye X, et al. Gut microbiota in children with juvenile idiopathic arthritis: characteristics, biomarker identification, and usefulness in clinical prediction. BMC Genomics 2020; 21 : 286. [CrossRef] [PubMed] [Google Scholar]
  19. Stoll ML, Kumar R, Morrow CD, et al. Altered microbiota associated with abnormal humoral immune responses to commensal organisms in enthesitis-related arthritis. Arthritis Res Ther 2014 ; 16 : 486. [CrossRef] [PubMed] [Google Scholar]
  20. Stoll ML, Weiss PF, Weiss JE, et al. Age and fecal microbial strain-specific differences in patients with spondyloarthritis. Arthritis Res Ther 2018 ; 20 : 14. [CrossRef] [PubMed] [Google Scholar]
  21. Tejesvi MV, Arvonen M, Kangas SM, et al. Faecal microbiome in new-onset juvenile idiopathic arthritis. Eur J Clin Microbiol Infect Dis 2016 ; 35 : 363–370. [CrossRef] [PubMed] [Google Scholar]
  22. Aggarwal A, Sarangi AN, Gaur P, et al. Gut microbiome in children with enthesitis-related arthritis in a developing country and the effect of probiotic administration. Clin Exp Immunol 2017 ; 187 : 480–489. [CrossRef] [PubMed] [Google Scholar]
  23. Muller PH, de Meij TGJ, Westedt M, et al. Disturbance of Microbial Core Species in New-Onset Juvenile Idiopathic Arthritis. J Pediatr Infect Dis 2017 ; 12 : 131–135. [CrossRef] [Google Scholar]
  24. Stoll ML, Kumar R, Lefkowitz EJ, et al. Fecal metabolomics in pediatric spondyloarthritis implicate decreased metabolic diversity and altered tryptophan metabolism as pathogenic factors. Genes Immun 2016 ; 17 : 400–405. [CrossRef] [PubMed] [Google Scholar]
  25. Winter J, Jung S, Keller S, et al. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 2009 ; 11 : 228–234. [CrossRef] [PubMed] [Google Scholar]
  26. Weber JA, Baxter DH, Zhang S, et al. The microRNA spectrum in 12 body fluids. Clin Chem 2010 ; 56 : 1733–1741. [CrossRef] [PubMed] [Google Scholar]
  27. Nziza N, Duroux-Richard I, Apparailly F. MicroRNAs in juvenile idiopathic arthritis: Can we learn more about pathophysiological mechanisms?. Autoimmun Rev 2019 ; 18 : 796–804. [CrossRef] [PubMed] [Google Scholar]
  28. O’Connell RM, Rao DS, Baltimore D. microRNA regulation of inflammatory responses. Annu Rev Immunol 2012 ; 30 : 295–312. [CrossRef] [PubMed] [Google Scholar]
  29. Orczyk K, Smolewska E. The Potential Importance of MicroRNAs as Novel Indicators How to Manage Patients with Juvenile Idiopathic Arthritis More Effectively. J Immunol Res 2021; 2021 : 9473508. [CrossRef] [Google Scholar]
  30. Kamiya Y, Kawada J, Kawano Y, et al. Serum microRNAs as Potential Biomarkers of Juvenile Idiopathic Arthritis. Clin Rheumatol 2015 ; 34 : 1705–1712. [CrossRef] [PubMed] [Google Scholar]
  31. Ma X, Wu F, Xin L, et al. Differential plasma microRNAs expression in juvenile idiopathic arthritis. Mod Rheumatol 2016 ; 26 : 224–232. [CrossRef] [PubMed] [Google Scholar]
  32. Schulert GS, Fall N, Harley JB, et al. Monocyte MicroRNA Expression in Active Systemic Juvenile Idiopathic Arthritis Implicates MicroRNA-125a-5p in Polarized Monocyte Phenotypes. Arthritis Rheumatol Hoboken NJ 2016 ; 68 : 2300–2313. [CrossRef] [Google Scholar]
  33. Nziza N, Jeziorski E, Delpont M, et al. Synovial-Fluid miRNA Signature for Diagnosis of Juvenile Idiopathic Arthritis. Cells 2019 ; 8 : 1521. [CrossRef] [PubMed] [Google Scholar]
  34. Rajendiran A, Klemm P, Schippers A, et al. miR-23a contributes to T cellular redox metabolism in juvenile idiopathic oligoarthritis. Rheumatol 2022; 61 : 2694–703. [CrossRef] [PubMed] [Google Scholar]
  35. Liu S, da Cunha AP, Rezende RM, et al. The Host Shapes the Gut Microbiota via Fecal microRNA. Cell Host Microbe 2016 ; 19 : 32–43. [CrossRef] [PubMed] [Google Scholar]
  36. Casado-Bedmar M, Viennois E. MicroRNA and Gut Microbiota: Tiny but Mighty-Novel Insights into Their Cross-talk in Inflammatory Bowel Disease Pathogenesis and Therapeutics. J Crohns Colitis 2022; 16 : 992–1005. [CrossRef] [PubMed] [Google Scholar]
  37. Viennois E, Chassaing B, Tahsin A, et al. Host-derived fecal microRNAs can indicate gut microbiota healthiness and ability to induce inflammation. Theranostics 2019 ; 9 : 4542–4557. [CrossRef] [PubMed] [Google Scholar]
  38. Masi L, Capobianco I, Magrì C, et al. MicroRNAs as Innovative Biomarkers for Inflammatory Bowel Disease and Prediction of Colorectal Cancer. Int J Mol Sci 2022; 23 : 7991. [CrossRef] [PubMed] [Google Scholar]
  39. Schönauen K, Le N, von Arnim U, et al. Circulating and Fecal microRNAs as Biomarkers for Inflammatory Bowel Diseases. Inflamm Bowel Dis 2018 ; 24 : 1547–1557. [CrossRef] [PubMed] [Google Scholar]
  40. Sun J, Feng M, Wu F, et al. Plasma miR-26a as a Diagnostic Biomarker Regulates Cytokine Expression in Systemic Juvenile Idiopathic Arthritis. J Rheumatol 2016 ; 43 : 1607–1614. [CrossRef] [PubMed] [Google Scholar]
  41. Lashine YA, Salah S, Aboelenein HR, et al. Correcting the expression of miRNA-155 represses PP2Ac and enhances the release of IL-2 in PBMCs of juvenile SLE patients. Lupus 2015 ; 24 : 240–247. [CrossRef] [PubMed] [Google Scholar]
  42. Fan Z-D, Cao Q, Huang N, et al. MicroRNA-125b regulates Th17/Treg cell differentiation and is associated with juvenile idiopathic arthritis. World J Pediatr 2020; 16 : 99–110. [CrossRef] [PubMed] [Google Scholar]
  43. Li H-W, Xie Y, Li F, et al. Effect of miR-19a and miR-21 on the JAK/STAT signaling pathway in the peripheral blood mononuclear cells of patients with systemic juvenile idiopathic arthritis. Exp Ther Med 2016 ; 11 : 2531–2536. [CrossRef] [PubMed] [Google Scholar]
  44. Hu Z, Jiang K, Frank MB, et al. Complexity and Specificity of the Neutrophil Transcriptomes in Juvenile Idiopathic Arthritis. Sci Rep 2016 ; 6 : 27453. [CrossRef] [PubMed] [Google Scholar]
  45. Berntson L, Agback P, Dicksved J. Changes in fecal microbiota and metabolomics in a child with juvenile idiopathic arthritis (JIA) responding to two treatment periods with exclusive enteral nutrition (EEN). Clin Rheumatol 2016 ; 35 : 1501–1506. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.